Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

SARS-CoV-2 emerging variants display enhanced syncytia formation

SARS-CoV-2 emerging variants display enhanced syncytia formation

Using a new public antibody to understand SARS-CoV-2 neutralization

Using a new public antibody to understand SARS-CoV-2 neutralization

Two-mAb cocktail prevents SARS-CoV-2 infection, study suggests

Two-mAb cocktail prevents SARS-CoV-2 infection, study suggests

Structure of monoclonal antibody that can potently neutralize SARS-CoV-2 and variants of concern

Structure of monoclonal antibody that can potently neutralize SARS-CoV-2 and variants of concern

Novel Assay Platform for 3D Microfluidic Cancer Research

Novel Assay Platform for 3D Microfluidic Cancer Research

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

SARS-CoV-2 infection aided by antibody-dependent enhancement

SARS-CoV-2 infection aided by antibody-dependent enhancement

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

Study finds strong evidence of transplacental passage of IgG antibodies following COVID vaccination

Study finds strong evidence of transplacental passage of IgG antibodies following COVID vaccination

Scientists create new compliance-based model for SARS-CoV-2 transmission

Scientists create new compliance-based model for SARS-CoV-2 transmission

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

Scientists identify potential antibody candidate with broad-spectrum neutralizing efficacy against SARS-CoV-2 variants

Scientists identify potential antibody candidate with broad-spectrum neutralizing efficacy against SARS-CoV-2 variants

Pfizer-BioNTech’s COVID-19 vaccine appears effective against SARS-CoV-2 mu variant

Pfizer-BioNTech’s COVID-19 vaccine appears effective against SARS-CoV-2 mu variant

B cell activating anti-CD73 antibody for the immunotherapy of COVID-19

B cell activating anti-CD73 antibody for the immunotherapy of COVID-19

Study shows prior COVID-19 and vaccination protects elderly against variants

Study shows prior COVID-19 and vaccination protects elderly against variants

Scientists develop 'elite' antibodies capable of defeating coronavirus variants at extremely low dosage

Scientists develop 'elite' antibodies capable of defeating coronavirus variants at extremely low dosage

Study reveals surfaces of SARS-CoV-2 spike most resistant to antibody escape

Study reveals surfaces of SARS-CoV-2 spike most resistant to antibody escape

Scientists publish a detailed map of where human antibodies bind to SARS-CoV-2

Scientists publish a detailed map of where human antibodies bind to SARS-CoV-2

No excess mortality during the Delta variant era in US state with high vaccination rates

No excess mortality during the Delta variant era in US state with high vaccination rates

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.